Dr. Anne Rani Pramila Anne, M.D.

Contact Dr. Anne

111 South 11th Street
Room G-301, Bodine Center
Philadelphia, PA 19107

(215) 955-6702
(215) 955-0412 fax


Medical School
University of Virginia, School of Medicine, Charlottesville, VA

Residency
Massachusetts General Hospital, Boston, MA

Board Certification
Radiation Oncology

Fellowship
Clinical Fellow in Radiation Oncology, Harvard University, School of Medicine, Boston, MA

Certifications
American Board of Radiology, Radiation Oncology, 1995

University Appointment
Associate Professor: 2007 - Present
Instructor: 1995 - 2007

Hospital Appointment
Thomas Jefferson University Hospital

Research and Clinical Interests
GI Cancer, Head & Neck Cancer, Breast Cancer, GYN Cancer

Publications

Most recent Peer-reviewed Publications

  1. Impact of a radiation oncology elective on the careers of young physicians: Update on a prospective cohort study
  2. Radiation therapy use and outcomes among older women with ER-positive and ER-negative stage I breast cancer
  3. Head and neck carcinoma in the United States: First comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN)
  4. Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer
  5. Implementation and experimental results of 4D tumor tracking using robotic couch
  6. Conditional survival probabilities for patients with resected pancreatic adenocarcinoma
  7. Assessing the value of an optional radiation oncology clinical rotation during the core clerkships in medical school
  8. Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies
  9. Radiation therapy oncology group 0247: A randomized phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer
  10. Toxicities after radioembolization with yttrium-90 SIR-spheres: Incidence and contributing risk factors at a single center
  11. The Influence of Prognostic Factors and Adjuvant Chemoradiation on Survival After Pancreaticoduodenectomy for Ampullary Carcinoma
  12. Side-branch embolization before 90Y radioembolization: Rate of recanalization and new collateral development
  13. Reirradiation of head and neck cancer with high-dose-rate brachytherapy: A customizable intraluminal solution for postoperative treatment of tracheal mucosa recurrence
  14. Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: A single-institution experience
  15. Does diabetes mellitus influence pathologic complete response and tumor downstaging after neoadjuvant chemoradiation for esophageal and gastroesophageal cancer? A two-institution report
  16. Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric cancer (RTOG-0114)
  17. Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer
  18. Distinguishing post-treatment changes from recurrent disease in cholangiocarcinoma: A case report
  19. Neck dissection followed by chemoradiotherapy for stage IV (N+) oropharynx cancer
  20. A Phase II trial of subcutaneous amifostine and radiation therapy in patients with head-and-neck cancer

View All Publications